Tests statins and ARBs for rheumatoid arthritis activity in Egyptian patients
Compares two drug types, statins and ARBs, in adults with rheumatoid arthritis.
Key facts
- Who runs it
- Sherief Abd-Elsalam
- Where
- Tanta, EgyptSee the site
- Trial code
- Registry title
- Statins and ARBs on Rheumatoid Activity
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 45 people, planned
- Started
- 1 Oct 2018
- Expected to end
- 1 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Angiotensin receptor blockers
- Statins
- Record updated
- 10 December 2018
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 65 with rheumatoid arthritis. It compares angiotensin receptor blockers and statins on disease activity.
- Age
- 18 Years to 65 Years
- Sex
- All sexes can join.
- Disease stage
- Rheumatoid arthritis. No stage or severity is given in the record.
Main reasons for not taking part
- Pregnant or breastfeeding
- Liver problems (hepatic impairment)
- Kidney problems (renal impairment)
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Rheumatoid arthritis
Who cannot take part
- Hepatic or renal impairment
- Pregnant or lactating
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in Egypt
- Sherief Abd-ElsalamTanta, EgyptContact: Ahmed El-Abd, MscTaking people
About the trial
What the trial wants to find out
Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients
The 3 groups in the trial
- Control groupNo study treatment, for comparison
No intervention
- Angiotensin receptor blockersExisting treatment, for comparison
ARB ( Angiotensin receptor blockers) + Traditional therpy.
- StatinsExisting treatment, for comparison
Statin + Traditional therapy.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients
- Plain-language title
- Tests statins and ARBs for rheumatoid arthritis activity in Egyptian patientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT03770702, who can take part
- Record updated
- 10 December 2018